We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01374165
Recruitment Status : Suspended (Study cancelled.)
First Posted : June 15, 2011
Last Update Posted : January 6, 2015
Information provided by (Responsible Party):
Prolong Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Primary Completion Date : No date given
  Study Completion Date : No date given